Kevin Cureton
President and Chief Executive Officer
Replay available
Solesence, Inc. (NASDAQ: SLSN) Q2 2026 earnings conference call, held 2026-08-19. Replay captured from the company's public earnings webcast.

President and Chief Executive Officer
Chief Financial Officer
Analyst, American Truce Investment Securities
Investor
Investor
and thank you for standing by. Welcome to the Celesence second quarter 2026 conference call. Today's call is being recorded. On today's call, we have Kevin Cureton, President and Chief Executive Officer of Celesence and Laura Riffner, Chief Financial Officer of Celesence. During this call, management will make statements that include forward-looking statements within the meaning of the federal securities law. which are pursuant to the safe harbor provision of the Private Security Litigation Reform Act of 1995. This conference may contain certain statements that reflect the company's current beliefs and a number of important factors that could cause actual results for future periods to differ materially from those stated on this call. These important factors include, without limitation, a decision of a customer to cancel purchase order or supply agreements, Demands for an acceptance of the company's personal care ingredients, advanced materials, and formulated products, changes in development and distribution relationships, the impact of competitive products and technology, possible disruption in commercial activities, occasioned by public health issues, terrorist activities, and armed conflict, and other risks indicated in the company's filings with the Security and Exchange Commission. Accept as required by federal security laws, the company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies. I'll now have the conference over to Kevin Cureton, President and Chief Executive Officer. Please go ahead, sir. Thank you, Lisa. And thank you to our investors, brand partners, and teammates who join us today for your continued support. We have an important issue to discuss today, the NT10Q...